Clinical Trial Update: A Study of Intraperitoneal and Intravenous Paclitaxel Plus Apatinib and S-1 Conversion Therapy for Gastric Cancer With Positive Exfoliative Cancer Cells [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating intraperitoneal and intravenous paclitaxel with apatinib and S-1 conversion therapy for gastric cancer with positive exfoliative cancer…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Cancer

Drugs mentioned

• Apatinib (apatinib)
• S-1 (tegafur/gimeracil/oteracil)
• paclitaxel (intraperitoneal and intravenous) (paclitaxel)

Snippet

Sponsor: Hebei Medical University | Conditions: Gastric Cancer With Positive Exfoliative Cancer Cells | Phase 2 | Status: UNKNOWN